Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. [electronic resource]
Producer: 20100811Description: 585-92 p. digitalISSN:- 1478-3231
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Apoptosis -- drug effects
- Blotting, Western
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Drug Synergism
- Durapatite -- pharmacology
- Female
- Genes, MDR -- drug effects
- Humans
- Liver Neoplasms -- drug therapy
- Mice
- Mice, Inbred BALB C
- Multidrug Resistance-Associated Proteins -- drug effects
- Neoplasms, Experimental -- drug therapy
- Probability
- RNA, Messenger -- metabolism
- Random Allocation
- Reverse Transcriptase Polymerase Chain Reaction
- Tumor Necrosis Factor-alpha -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.